Ensign Peak Advisors’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-454,981
| Closed | -$3.28M | – | 1689 |
|
|
2024
Q4 | $3.28M | Buy |
454,981
+128,204
| +39% | +$924K | 0.01% | 766 |
|
|
2024
Q3 | $2.01M | Hold |
326,777
| – | – | ﹤0.01% | 952 |
|
|
2024
Q2 | $2.17M | Hold |
326,777
| – | – | ﹤0.01% | 873 |
|
|
2024
Q1 | $3.33M | Hold |
326,777
| – | – | 0.01% | 766 |
|
|
2023
Q4 | $3.68M | Hold |
326,777
| – | – | 0.01% | 704 |
|
|
2023
Q3 | $850K | Hold |
326,777
| – | – | ﹤0.01% | 1322 |
|
|
2023
Q2 | $1.15M | Hold |
326,777
| – | – | ﹤0.01% | 1149 |
|
|
2023
Q1 | $1.38M | Buy |
326,777
+232,362
| +246% | +$981K | ﹤0.01% | 999 |
|
|
2022
Q4 | $1.55M | Buy |
94,415
+37,115
| +65% | +$611K | ﹤0.01% | 909 |
|
|
2022
Q3 | $732K | Buy |
+57,300
| New | +$732K | ﹤0.01% | 1249 |
|